Physician profile
Eric H Seem
NPI 1386627792
$546.96
in general payments reported to CMS, 2019-2025
7 companies · $58.13 in 2025
The $58.13 reported for 2025 was less than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $119 · 2022: $133 · 2023: $76.95 · 2024: $160 · 2025: $58.13.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $295.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $294.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $330.38 | 2021-2025 | Exparel, Iovera, Zilretta |
| Ambu INC. | $70.68 | 2023-2024 | |
| Silk Road Medical, INC. | $49.27 | 2023-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Kerecis Limited | $36.47 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Fisher & Paykel Healthcare INC | $24.38 | 2025 | Fisher & Paykel Healthcare |
| Conmed Corporation | $22.04 | 2024 | Airseal |
| Eagle Pharmaceuticals, INC. | $13.74 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Seem listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.